High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed

Clinical trial NCT06972602 · RECRUITING

Trial details

NCT number: NCT06972602
Sponsor: Eye & ENT Hospital of Fudan University
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Retinoblastoma Retinoblastoma, Recurrent

Start date: 2025-04-01
Primary completion: 2025-12-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.